MedTrace Logo

Evaluating the Effectiveness of Virtual Reality Application in Caesarean Section

NCT07080281 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2025-07-23

No results posted yet for this study

Summary

The aim of this study was to evaluate the effects of virtual reality intervention during cesarean delivery under spinal anesthesia on labor pain, anxiety, satisfaction and hemodynamic parameters in primiparous pregnant women.

The main questions it aims to answer are:

1. Is there a significant difference between the mean intraoperative pain scores of the pregnant women in the intervention group and those in the control group?
2. Is there a significant difference between the mean intraoperative anxiety scores of the pregnant women in the intervention group and those in the control group?
3. Is there a significant difference between the mean birth satisfaction scores of the pregnant women in the intervention group and those in the control group?
4. Is there a significant difference between the vital signs of pregnant women in the intervention group and those in the control group?
5. Is there a significant difference between the mean apgar scores of the pregnant women in the intervention group and those in the control group?

Conditions

  • Virtual Reality Pain Distraction
  • Birth Satisfaction
  • Vital Signs
  • Anxiety
  • Apgar Score
  • Virtual Reality

Interventions

DEVICE

Oculus Meta Quest 2 All In-One model virtual reality glasses

During the caesarean section, Meta Quest 2 All In-One model virtual reality glasses from Oculus were used for 15 minutes. In this virtual environment, the licensed product video "Breathe- Relax and Meditate" was watched via the "Meta Horizon" application.

Sponsors & Collaborators

  • Ankara Yildirim Beyazıt University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-15
Primary Completion
2025-06-01
Completion
2025-07-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07080281 on ClinicalTrials.gov